BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 35227773)

  • 1. Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma.
    Husain A; Chiu YT; Sze KM; Ho DW; Tsui YM; Suarez EMS; Zhang VX; Chan LK; Lee E; Lee JM; Cheung TT; Wong CC; Chung CY; Ng IO
    J Hepatol; 2022 Aug; 77(2):383-396. PubMed ID: 35227773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the roles of Ephrin-A3 in malignant peripheral nerve sheath tumor by TALENs.
    Wang Z; Liu Z; Liu B; Liu G; Wu S
    Oncol Rep; 2015 Jul; 34(1):391-8. PubMed ID: 25955218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EFNA3 long noncoding RNAs induced by hypoxia promote metastatic dissemination.
    Gómez-Maldonado L; Tiana M; Roche O; Prado-Cabrero A; Jensen L; Fernandez-Barral A; Guijarro-Muñoz I; Favaro E; Moreno-Bueno G; Sanz L; Aragones J; Harris A; Volpert O; Jimenez B; del Peso L
    Oncogene; 2015 May; 34(20):2609-20. PubMed ID: 25023702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
    Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
    Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorafenib blocks the activation of the HIF-2α/VEGFA/EphA2 pathway, and inhibits the rapid growth of residual liver cancer following high-intensity focused ultrasound therapy in vivo.
    Wu L; Zhou J; Zhou W; Huang XF; Chen Q; Wang W; Zhai L; Li S; Tang Z
    Pathol Res Pract; 2021 Apr; 220():153270. PubMed ID: 33640712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-26b Enhances the Radiosensitivity of Hepatocellular Carcinoma Cells by Targeting EphA2.
    Jin Q; Li XJ; Cao PG
    Tohoku J Exp Med; 2016 Feb; 238(2):143-51. PubMed ID: 26843134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of miR-520e-mediated MAPK signalling pathway on HBV replication and regulation of hepatocellular carcinoma cells via targeting EphA2.
    Tian JH; Liu WD; Zhang ZY; Tang LH; Li D; Tian ZJ; Lin SW; Li YJ
    J Viral Hepat; 2019 Apr; 26(4):496-505. PubMed ID: 30521133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop.
    Cui CP; Wong CC; Kai AK; Ho DW; Lau EY; Tsui YM; Chan LK; Cheung TT; Chok KS; Chan ACY; Lo RC; Lee JM; Lee TK; Ng IOL
    Gut; 2017 Dec; 66(12):2149-2159. PubMed ID: 28258134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.
    Youngblood VM; Kim LC; Edwards DN; Hwang Y; Santapuram PR; Stirdivant SM; Lu P; Ye F; Brantley-Sieders DM; Chen J
    Cancer Res; 2016 Apr; 76(7):1825-36. PubMed ID: 26833123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EFNA1 ligand and its receptor EphA2: potential biomarkers for hepatocellular carcinoma.
    Cui XD; Lee MJ; Yu GR; Kim IH; Yu HC; Song EY; Kim DG
    Int J Cancer; 2010 Feb; 126(4):940-9. PubMed ID: 19642143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2.
    Li H; Sun Q; Han B; Yu X; Hu B; Hu S
    Int J Clin Exp Pathol; 2015; 8(5):4782-90. PubMed ID: 26191168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Over-expression of miR-141 inhibits the proliferation, invasion and migration of hepatocellular carcinoma MHCC-97H cells].
    Yao B; Xue Y; Liu Z; Xu M; Tu K; Wang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1083-7. PubMed ID: 27412940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive prognostic and immunological analysis of ephrin family genes in hepatocellular carcinoma.
    Huang S; Dong C; Zhang J; Fu S; Lv Y; Wu J
    Front Mol Biosci; 2022; 9():943384. PubMed ID: 36052169
    [No Abstract]   [Full Text] [Related]  

  • 15. ATP-citrate lyase regulates stemness and metastasis in hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.
    Han Q; Chen CA; Yang W; Liang D; Lv HW; Lv GS; Zong QN; Wang HY
    Hepatobiliary Pancreat Dis Int; 2021 Jun; 20(3):251-261. PubMed ID: 33129711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma.
    Mo Z; Liu D; Rong D; Zhang S
    Front Immunol; 2021; 12():611058. PubMed ID: 33679749
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between ephrin-A1 mRNA expression and poor prognosis after hepatectomy to treat hepatocellular carcinoma.
    Wada H; Yamamoto H; Kim C; Uemura M; Akita H; Tomimaru Y; Hama N; Kawamoto K; Kobayashi S; Eguchi H; Umeshita K; Doki Y; Mori M; Nagano H
    Int J Oncol; 2014 Sep; 45(3):1051-8. PubMed ID: 24969670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene.
    Sukka-Ganesh B; Mohammed KA; Kaye F; Goldberg EP; Nasreen N
    BMC Cancer; 2012 Jul; 12():309. PubMed ID: 22824143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypoxia-inducible factor 1 inhibitor LW6 mediates the HIF-1α/PD-L1 axis and suppresses tumor growth of hepatocellular carcinoma in vitro and in vivo.
    Xu H; Chen Y; Li Z; Zhang H; Liu J; Han J
    Eur J Pharmacol; 2022 Sep; 930():175154. PubMed ID: 35868447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP citrate lyase inhibitor triggers endoplasmic reticulum stress to induce hepatocellular carcinoma cell apoptosis via p-eIF2α/ATF4/CHOP axis.
    Zheng Y; Zhou Q; Zhao C; Li J; Yu Z; Zhu Q
    J Cell Mol Med; 2021 Feb; 25(3):1468-1479. PubMed ID: 33393219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.